Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 26, 2019 Off

2019 Market Spotlight: Erectile Dysfunction – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Erectile Dysfunction” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Erectile…

June 26, 2019 Off

LineaRx Ships DNA to Support Therapy Development for Neurodegenerative Diseases

By BusinessWire

Interest in large-scale Linear DNA for nucleic acid-based therapies continues to rise STONY BROOK, N.Y.–(BUSINESS WIRE)–$apdn #alzheimers–LineaRx, Inc. a wholly-owned…

June 26, 2019 Off

Promega 2019 Corporate Responsibility Report Highlights Commitments to Environmental Sustainability, Employee Well-Being and Community Support

By BusinessWire

MADISON, Wis.–(BUSINESS WIRE)–#CSR–Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices…

June 26, 2019 Off

Combination Anti-diabetes Drugs Market – Global Growth, Trends, and Forecast 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Combination Anti-diabetes Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…

June 26, 2019 Off

Depressive Disorders Pipeline Review, Developer Landscape and Competitive Insights, 2010-2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Depressive Disorders: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. The Depressive…

June 26, 2019 Off

X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome

By BusinessWire

Global 4WHIM trial marks first-ever Phase 3 study in patients with WHIM syndrome CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq:XFOR), a…

June 26, 2019 Off

Odonate Therapeutics Announces Pricing of Public Offering of Shares of Common Stock

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…

Taris Bio brings strong evidence of TAR-200’s anti-tumor activity
June 26, 2019 Off

Taris Bio brings strong evidence of TAR-200’s anti-tumor activity

By Dino Mustafić

TARIS Bio posted on Wednesday positive data from its Phase 1b study of TAR-200 for the treatment of patients with muscle invasive bladder cancer (MIBC), neoadjuvant to radical cystectomy (RC).

June 26, 2019 Off

What Are the Key Roadblocks Facing Pharmaceutical Companies in 2019? Infiniti Reveals the Pharmaceutical Industry Challenges to Watch out for This Year

By BusinessWire

LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on the pharmaceutical industry…

June 26, 2019 Off

Kymriah (tisagenlecleucel; Novartis) Overview 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Kymriah” report has been added to ResearchAndMarkets.com’s offering. Kymriah (tisagenlecleucel; Novartis) is a cluster of differentiation (CD)19-targeted genetically…

Posts pagination

Previous 1 … 3,045 3,046 3,047 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine